Bevacizumab (B) plus immunotherapy and chemotherapy (BIC) in patients with metastatic renal cell cancer (mRCC). Dose-finding/phase II trial / Buti, S; Brighenti, M; Dalla Chiesa, M; Simonelli, C; Passalacqua, R. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 18:supplement 4(2007), pp. 39-39.

Bevacizumab (B) plus immunotherapy and chemotherapy (BIC) in patients with metastatic renal cell cancer (mRCC). Dose-finding/phase II trial

Buti S;
2007-01-01

2007
Bevacizumab (B) plus immunotherapy and chemotherapy (BIC) in patients with metastatic renal cell cancer (mRCC). Dose-finding/phase II trial / Buti, S; Brighenti, M; Dalla Chiesa, M; Simonelli, C; Passalacqua, R. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 18:supplement 4(2007), pp. 39-39.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2906922
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact